Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 50 entries
Sorted by: Best Match Show Resources per page
Lithium overdosage and related tests.

International journal of bipolar disorders

Pigatto PD, Dell'Osso B, Guzzi G.
PMID: 26753697
Int J Bipolar Disord. 2016 Dec;4(1):1. doi: 10.1186/s40345-015-0044-y. Epub 2016 Jan 12.

Lithium acts biochemically through the inositol depletion in brain cortex. At low doses, however, it is partly effective and/or ineffective, whereas in high concentrations is toxic. We would like to make one point about this review. In fact, in...

Cite
Pigatto PD, Dell'Osso B, Guzzi G. Lithium overdosage and related tests. Int J Bipolar Disord. 2016;4(1):1doi: 10.1186/s40345-015-0044-y.
Pigatto, P. D., Dell'Osso, B., & Guzzi, G. (2016). Lithium overdosage and related tests. International journal of bipolar disorders, 4(1), 1. https://doi.org/10.1186/s40345-015-0044-y
Pigatto, Paolo D, et al. "Lithium overdosage and related tests." International journal of bipolar disorders vol. 4,1 (2016): 1. doi: https://doi.org/10.1186/s40345-015-0044-y
Pigatto PD, Dell'Osso B, Guzzi G. Lithium overdosage and related tests. Int J Bipolar Disord. 2016 Dec;4(1):1. doi: 10.1186/s40345-015-0044-y. Epub 2016 Jan 12. PMID: 26753697; PMCID: PMC4709333.
Copy Download .nbib Format: NLM
Beneficial Effects of Antioxidant Furfuryl Palmitate in Non-pharmacologic Treatments (Prescription Emollient Devices, PEDs) for Atopic Dermatitis and Related Skin Disorders.

Dermatology and therapy

Pigatto PD, Diani M.
PMID: 29790104
Dermatol Ther (Heidelb). 2018 Sep;8(3):339-347. doi: 10.1007/s13555-018-0239-0. Epub 2018 May 22.

INTRODUCTION: Atopic dermatitis (AD) is a common chronic inflammatory skin disease; it requires long-term treatments focused on symptomatic relief. Current first-line treatments include moisturizers and topical corticosteroids. Recently, topical antioxidants have been added to moisturizer formulations to alleviate mild-to-moderate...

Cite
Pigatto PD, Diani M. Beneficial Effects of Antioxidant Furfuryl Palmitate in Non-pharmacologic Treatments (Prescription Emollient Devices, PEDs) for Atopic Dermatitis and Related Skin Disorders. Dermatol Ther (Heidelb). 2018;8(3):339-347doi: 10.1007/s13555-018-0239-0.
Pigatto, P. D., & Diani, M. (2018). Beneficial Effects of Antioxidant Furfuryl Palmitate in Non-pharmacologic Treatments (Prescription Emollient Devices, PEDs) for Atopic Dermatitis and Related Skin Disorders. Dermatology and therapy, 8(3), 339-347. https://doi.org/10.1007/s13555-018-0239-0
Pigatto, Paolo Daniele, and Diani, Marco. "Beneficial Effects of Antioxidant Furfuryl Palmitate in Non-pharmacologic Treatments (Prescription Emollient Devices, PEDs) for Atopic Dermatitis and Related Skin Disorders." Dermatology and therapy vol. 8,3 (2018): 339-347. doi: https://doi.org/10.1007/s13555-018-0239-0
Pigatto PD, Diani M. Beneficial Effects of Antioxidant Furfuryl Palmitate in Non-pharmacologic Treatments (Prescription Emollient Devices, PEDs) for Atopic Dermatitis and Related Skin Disorders. Dermatol Ther (Heidelb). 2018 Sep;8(3):339-347. doi: 10.1007/s13555-018-0239-0. Epub 2018 May 22. PMID: 29790104; PMCID: PMC6109026.
Copy Download .nbib Format: NLM
Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis.

World journal of hepatology

Damiani G, Leone S, Fajgenbaum K, Bragazzi NL, Pacifico A, Conic RR, Pigatto PD, Maiorana C, Poli P, Berti E, Pace MC, Malagoli P, Bettoli V, Fiore M.
PMID: 31114643
World J Hepatol. 2019 Apr 27;11(4):391-401. doi: 10.4254/wjh.v11.i4.391.

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) includes two distinct conditions, with different histologic features and prognosis: non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). Furthermore, NASH is the more aggressive necro-inflammatory form, which may accumulate fibrosis and result in...

Cite
Damiani G, Leone S, Fajgenbaum K, et al. Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis. World J Hepatol. 2019;11(4):391-401doi: 10.4254/wjh.v11.i4.391.
Damiani, G., Leone, S., Fajgenbaum, K., Bragazzi, N. L., Pacifico, A., Conic, R. R., Pigatto, P. D., Maiorana, C., Poli, P., Berti, E., Pace, M. C., Malagoli, P., Bettoli, V., & Fiore, M. (2019). Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis. World journal of hepatology, 11(4), 391-401. https://doi.org/10.4254/wjh.v11.i4.391
Damiani, Giovanni, et al. "Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis." World journal of hepatology vol. 11,4 (2019): 391-401. doi: https://doi.org/10.4254/wjh.v11.i4.391
Damiani G, Leone S, Fajgenbaum K, Bragazzi NL, Pacifico A, Conic RR, Pigatto PD, Maiorana C, Poli P, Berti E, Pace MC, Malagoli P, Bettoli V, Fiore M. Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis. World J Hepatol. 2019 Apr 27;11(4):391-401. doi: 10.4254/wjh.v11.i4.391. PMID: 31114643; PMCID: PMC6504856.
Copy Download .nbib Format: NLM
Photoletter to the editor: Exfoliative cheilitis associated with titanium dental implants and mercury amalgam.

Journal of dermatological case reports

Pigatto PD, Berti E, Spadari F, Bombeccari GP, Guzzi G.
PMID: 22408710
J Dermatol Case Rep. 2011 Dec 12;5(4):89-90. doi: 10.3315/jdcr.2011.1084.

Exfoliative cheilitis is an uncommon chronic inflammatory condition that generally affects the vermilion of the lips. Its cause is still largely unknown an there is no effective treatment. Here we report of a case of exfoliative cheilitis possibly caused...

Cite
Pigatto PD, Berti E, Spadari F, et al. Photoletter to the editor: Exfoliative cheilitis associated with titanium dental implants and mercury amalgam. J Dermatol Case Rep. 2011;5(4):89-90doi: 10.3315/jdcr.2011.1084.
Pigatto, P. D., Berti, E., Spadari, F., Bombeccari, G. P., & Guzzi, G. (2011). Photoletter to the editor: Exfoliative cheilitis associated with titanium dental implants and mercury amalgam. Journal of dermatological case reports, 5(4), 89-90. https://doi.org/10.3315/jdcr.2011.1084
Pigatto, Paolo D, et al. "Photoletter to the editor: Exfoliative cheilitis associated with titanium dental implants and mercury amalgam." Journal of dermatological case reports vol. 5,4 (2011): 89-90. doi: https://doi.org/10.3315/jdcr.2011.1084
Pigatto PD, Berti E, Spadari F, Bombeccari GP, Guzzi G. Photoletter to the editor: Exfoliative cheilitis associated with titanium dental implants and mercury amalgam. J Dermatol Case Rep. 2011 Dec 12;5(4):89-90. doi: 10.3315/jdcr.2011.1084. PMID: 22408710; PMCID: PMC3241953.
Copy Download .nbib Format: NLM
Bilateral Optic Disc Edema in a Patient with Lead Poisoning.

Journal of ophthalmic & vision research

Pigatto P, Guzzi G.
PMID: 34394882
J Ophthalmic Vis Res. 2021 Jul 29;16(3):524-525. doi: 10.18502/jovr.v16i3.9450. eCollection 2021.

No abstract available.

Cite
Pigatto P, Guzzi G. Bilateral Optic Disc Edema in a Patient with Lead Poisoning. J Ophthalmic Vis Res. 2021;16(3):524-525doi: 10.18502/jovr.v16i3.9450.
Pigatto, P., & Guzzi, G. (2021). Bilateral Optic Disc Edema in a Patient with Lead Poisoning. Journal of ophthalmic & vision research, 16(3), 524-525. https://doi.org/10.18502/jovr.v16i3.9450
Pigatto, Paolo, and Guzzi, Gianpaolo. "Bilateral Optic Disc Edema in a Patient with Lead Poisoning." Journal of ophthalmic & vision research vol. 16,3 (2021): 524-525. doi: https://doi.org/10.18502/jovr.v16i3.9450
Pigatto P, Guzzi G. Bilateral Optic Disc Edema in a Patient with Lead Poisoning. J Ophthalmic Vis Res. 2021 Jul 29;16(3):524-525. doi: 10.18502/jovr.v16i3.9450. eCollection 2021. PMID: 34394882; PMCID: PMC8358748.
Copy Download .nbib Format: NLM
Therapeutic management of chronic spontaneous urticaria in clinical practice: results from a pilot survey.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia

Cassano N, Genovese G, Asero R, Crimi N, Cristaudo A, Dapavo P, De Pità O, Ferrucci SM, Fierro MT, Foti C, Girolomoni G, Nettis E, Offidani A, Patrizi A, Pepe P, Pigatto P, Stingeni L, Marzano AV, Vena GA.
PMID: 33228338
G Ital Dermatol Venereol. 2020 Nov 23; doi: 10.23736/S0392-0488.20.06761-9. Epub 2020 Nov 23.

BACKGROUND: The therapeutic approaches to patients with chronic spontaneous urticaria (CSU) differ among health care professionals and may be influenced by many factors.OBJECTIVES: This cross-sectional survey was aimed at evaluating physicians' attitudes regarding therapeutic management of CSU on clinical...

Cite
Cassano N, Genovese G, Asero R, et al. Therapeutic management of chronic spontaneous urticaria in clinical practice: results from a pilot survey. G Ital Dermatol Venereol. 2020;doi: 10.23736/S0392-0488.20.06761-9.
Cassano, N., Genovese, G., Asero, R., Crimi, N., Cristaudo, A., Dapavo, P., De Pità, O., Ferrucci, S. M., Fierro, M. T., Foti, C., Girolomoni, G., Nettis, E., Offidani, A., Patrizi, A., Pepe, P., Pigatto, P., Stingeni, L., Marzano, A. V., & Vena, G. A. (2020). Therapeutic management of chronic spontaneous urticaria in clinical practice: results from a pilot survey. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, . https://doi.org/10.23736/S0392-0488.20.06761-9
Cassano, Nicoletta, et al. "Therapeutic management of chronic spontaneous urticaria in clinical practice: results from a pilot survey." Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia vol. (2020). doi: https://doi.org/10.23736/S0392-0488.20.06761-9
Cassano N, Genovese G, Asero R, Crimi N, Cristaudo A, Dapavo P, De Pità O, Ferrucci SM, Fierro MT, Foti C, Girolomoni G, Nettis E, Offidani A, Patrizi A, Pepe P, Pigatto P, Stingeni L, Marzano AV, Vena GA. Therapeutic management of chronic spontaneous urticaria in clinical practice: results from a pilot survey. G Ital Dermatol Venereol. 2020 Nov 23; doi: 10.23736/S0392-0488.20.06761-9. Epub 2020 Nov 23. PMID: 33228338.
Copy Download .nbib Format: NLM
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.

Journal of autoimmunity

Ferri C, Ursini F, Gragnani L, Raimondo V, Giuggioli D, Foti R, Caminiti M, Olivo D, Cuomo G, Visentini M, Cacciapaglia F, Pellegrini R, Pigatto E, Urraro T, Naclerio C, Tavoni A, Puccetti L, Varcasia G, Cavazzana I, L'Andolina M, Ruscitti P, Vadacca M, Gigliotti P, La Gualana F, Cozzi F, Spinella A, Visalli E, Dal Bosco Y, Amato G, Masini F, Pagano Mariano G, Brittelli R, Aiello V, Caminiti R, Scorpiniti D, Rechichi G, Ferrari T, Monti M, Elia G, Franceschini F, Meliconi R, Casato M, Iannone F, Giacomelli R, Fallahi P, Santini SA, Zignego AL, Antonelli A.
PMID: 34781162
J Autoimmun. 2021 Dec;125:102744. doi: 10.1016/j.jaut.2021.102744. Epub 2021 Nov 10.

Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19 vaccines. Our prospective observational multicenter study aimed to evaluate the seroconversion after the vaccination cycle and at 6-12-month follow-up, as well the safety and efficacy of vaccines in preventing...

Cite
Ferri C, Ursini F, Gragnani L, et al. Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups. J Autoimmun. 2021;125:102744doi: 10.1016/j.jaut.2021.102744.
Ferri, C., Ursini, F., Gragnani, L., Raimondo, V., Giuggioli, D., Foti, R., Caminiti, M., Olivo, D., Cuomo, G., Visentini, M., Cacciapaglia, F., Pellegrini, R., Pigatto, E., Urraro, T., Naclerio, C., Tavoni, A., Puccetti, L., Varcasia, G., Cavazzana, I., L'Andolina, M., Ruscitti, P., Vadacca, M., Gigliotti, P., La Gualana, F., Cozzi, F., Spinella, A., Visalli, E., Dal Bosco, Y., Amato, G., Masini, F., Pagano Mariano, G., Brittelli, R., Aiello, V., Caminiti, R., Scorpiniti, D., Rechichi, G., Ferrari, T., Monti, M., Elia, G., Franceschini, F., Meliconi, R., Casato, M., Iannone, F., Giacomelli, R., Fallahi, P., Santini, S. A., Zignego, A. L., & Antonelli, A. (2021). Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups. Journal of autoimmunity, 125102744. https://doi.org/10.1016/j.jaut.2021.102744
Ferri, Clodoveo, et al. "Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups." Journal of autoimmunity vol. 125 (2021): 102744. doi: https://doi.org/10.1016/j.jaut.2021.102744
Ferri C, Ursini F, Gragnani L, Raimondo V, Giuggioli D, Foti R, Caminiti M, Olivo D, Cuomo G, Visentini M, Cacciapaglia F, Pellegrini R, Pigatto E, Urraro T, Naclerio C, Tavoni A, Puccetti L, Varcasia G, Cavazzana I, L'Andolina M, Ruscitti P, Vadacca M, Gigliotti P, La Gualana F, Cozzi F, Spinella A, Visalli E, Dal Bosco Y, Amato G, Masini F, Pagano Mariano G, Brittelli R, Aiello V, Caminiti R, Scorpiniti D, Rechichi G, Ferrari T, Monti M, Elia G, Franceschini F, Meliconi R, Casato M, Iannone F, Giacomelli R, Fallahi P, Santini SA, Zignego AL, Antonelli A. Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups. J Autoimmun. 2021 Dec;125:102744. doi: 10.1016/j.jaut.2021.102744. Epub 2021 Nov 10. PMID: 34781162; PMCID: PMC8577991.
Copy Download .nbib Format: NLM
Chemical Exposure, Risk of Multiple Chemical Sensitivity, and Occupational Safety.

Safety and health at work

Pigatto PD, Ronchi A, Guzzi G.
PMID: 32995065
Saf Health Work. 2020 Sep;11(3):383-384. doi: 10.1016/j.shaw.2020.05.006. Epub 2020 Jun 12.

No abstract available.

Cite
Pigatto PD, Ronchi A, Guzzi G. Chemical Exposure, Risk of Multiple Chemical Sensitivity, and Occupational Safety. Saf Health Work. 2020;11(3):383-384doi: 10.1016/j.shaw.2020.05.006.
Pigatto, P. D., Ronchi, A., & Guzzi, G. (2020). Chemical Exposure, Risk of Multiple Chemical Sensitivity, and Occupational Safety. Safety and health at work, 11(3), 383-384. https://doi.org/10.1016/j.shaw.2020.05.006
Pigatto, Paolo D, et al. "Chemical Exposure, Risk of Multiple Chemical Sensitivity, and Occupational Safety." Safety and health at work vol. 11,3 (2020): 383-384. doi: https://doi.org/10.1016/j.shaw.2020.05.006
Pigatto PD, Ronchi A, Guzzi G. Chemical Exposure, Risk of Multiple Chemical Sensitivity, and Occupational Safety. Saf Health Work. 2020 Sep;11(3):383-384. doi: 10.1016/j.shaw.2020.05.006. Epub 2020 Jun 12. PMID: 32995065; PMCID: PMC7502604.
Copy Download .nbib Format: NLM
Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018-2019.

Contact dermatitis

Stingeni L, Marietti R, Bianchi L, Guarneri F, Ferrucci SM, Faraci AG, Foti C, Romita P, Patruno C, Napolitano M, Gallo R, Corazza M, Schena D, Milanesi N, Bruni F, Pigatto P, Musumeci ML, Martina E, Piras V, Tramontana M, Hansel K.
PMID: 33931866
Contact Dermatitis. 2021 Sep;85(3):317-323. doi: 10.1111/cod.13873. Epub 2021 May 24.

BACKGROUND: Budesonide was included in the European Baseline Series in 2000 as the most suitable marker forcorticosteroid hypersensitivity. In the last two decades, a decreasing trend of budesonide allergy has been observed.OBJECTIVES: To estimate the prevalence of positive patch...

Cite
Stingeni L, Marietti R, Bianchi L, et al. Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018-2019. Contact Dermatitis. 2021;85(3):317-323doi: 10.1111/cod.13873.
Stingeni, L., Marietti, R., Bianchi, L., Guarneri, F., Ferrucci, S. M., Faraci, A. G., Foti, C., Romita, P., Patruno, C., Napolitano, M., Gallo, R., Corazza, M., Schena, D., Milanesi, N., Bruni, F., Pigatto, P., Musumeci, M. L., Martina, E., Piras, V., Tramontana, M., & Hansel, K. (2021). Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018-2019. Contact dermatitis, 85(3), 317-323. https://doi.org/10.1111/cod.13873
Stingeni, Luca, et al. "Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018-2019." Contact dermatitis vol. 85,3 (2021): 317-323. doi: https://doi.org/10.1111/cod.13873
Stingeni L, Marietti R, Bianchi L, Guarneri F, Ferrucci SM, Faraci AG, Foti C, Romita P, Patruno C, Napolitano M, Gallo R, Corazza M, Schena D, Milanesi N, Bruni F, Pigatto P, Musumeci ML, Martina E, Piras V, Tramontana M, Hansel K. Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018-2019. Contact Dermatitis. 2021 Sep;85(3):317-323. doi: 10.1111/cod.13873. Epub 2021 May 24. PMID: 33931866.
Copy Download .nbib Format: NLM
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis.

The Journal of dermatological treatment

Fargnoli MC, Esposito M, Ferrucci S, Girolomoni G, Offidani A, Patrizi A, Peris K, Costanzo A, Malara G, Pellacani G, Romanelli M, Amerio P, Cristaudo A, Flori ML, Motolese A, Betto P, Patruno C, Pigatto P, Peccianti C, Stinco G, Zalaudek I, Bianchi L, Boccaletti V, Cannavo SP, Cusano F, Lembo S, Mozzillo R, Gallo R, Potenza C, Rongioletti F, Tiberio R, Grieco T, Micali G, Persechino S, Pettinato M, Pucci S, Stingeni L, Caruso C, Argenziano G.
PMID: 32436765
J Dermatolog Treat. 2020 Jul 03;1-4. doi: 10.1080/09546634.2020.1773379. Epub 2020 Jul 03.

No abstract available.

Cite
Fargnoli MC, Esposito M, Ferrucci S, et al. A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis. J Dermatolog Treat. 2020;1-4doi: 10.1080/09546634.2020.1773379.
Fargnoli, M. C., Esposito, M., Ferrucci, S., Girolomoni, G., Offidani, A., Patrizi, A., Peris, K., Costanzo, A., Malara, G., Pellacani, G., Romanelli, M., Amerio, P., Cristaudo, A., Flori, M. L., Motolese, A., Betto, P., Patruno, C., Pigatto, P., Peccianti, C., Stinco, G., Zalaudek, I., Bianchi, L., Boccaletti, V., Cannavo, S. P., Cusano, F., Lembo, S., Mozzillo, R., Gallo, R., Potenza, C., Rongioletti, F., Tiberio, R., Grieco, T., Micali, G., Persechino, S., Pettinato, M., Pucci, S., Stingeni, L., Caruso, C., & Argenziano, G. (2020). A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis. The Journal of dermatological treatment, 1-4. https://doi.org/10.1080/09546634.2020.1773379
Fargnoli, M C, et al. "A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis." The Journal of dermatological treatment vol. (2020): 1-4. doi: https://doi.org/10.1080/09546634.2020.1773379
Fargnoli MC, Esposito M, Ferrucci S, Girolomoni G, Offidani A, Patrizi A, Peris K, Costanzo A, Malara G, Pellacani G, Romanelli M, Amerio P, Cristaudo A, Flori ML, Motolese A, Betto P, Patruno C, Pigatto P, Peccianti C, Stinco G, Zalaudek I, Bianchi L, Boccaletti V, Cannavo SP, Cusano F, Lembo S, Mozzillo R, Gallo R, Potenza C, Rongioletti F, Tiberio R, Grieco T, Micali G, Persechino S, Pettinato M, Pucci S, Stingeni L, Caruso C, Argenziano G. A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis. J Dermatolog Treat. 2020 Jul 03;1-4. doi: 10.1080/09546634.2020.1773379. Epub 2020 Jul 03. PMID: 32436765.
Copy Download .nbib Format: NLM
Adjustable Silicone Gastric Banding (ASGB): the Italian experience.

Obesity surgery

Favretti F, Enzi G, Pizzirani E, Segato G, Belluco C, Pigato P, Busetto L, De Marchi F, Lise M.
PMID: 10757905
Obes Surg. 1993 Feb;3(1):53-56. doi: 10.1381/096089293765559773.

Adjustable silicone gastric banding (ASGB) is a recently introduced gastric restrictive procedure. From April 1990 to April 1992, 85 patients underwent ASGB at our Department. Patients' characteristics were: 65 females, 20 males, mean age 39.6 years (range 17-60 years);...

Cite
Favretti F, Enzi G, Pizzirani E, et al. Adjustable Silicone Gastric Banding (ASGB): the Italian experience. Obes Surg. 1993;3(1):53-56doi: 10.1381/096089293765559773.
Favretti, F., Enzi, G., Pizzirani, E., Segato, G., Belluco, C., Pigato, P., Busetto, L., De Marchi F, & Lise, M. (1993). Adjustable Silicone Gastric Banding (ASGB): the Italian experience. Obesity surgery, 3(1), 53-56. https://doi.org/10.1381/096089293765559773
Favretti, et al. "Adjustable Silicone Gastric Banding (ASGB): the Italian experience." Obesity surgery vol. 3,1 (1993): 53-56. doi: https://doi.org/10.1381/096089293765559773
Favretti F, Enzi G, Pizzirani E, Segato G, Belluco C, Pigato P, Busetto L, De Marchi F, Lise M. Adjustable Silicone Gastric Banding (ASGB): the Italian experience. Obes Surg. 1993 Feb;3(1):53-56. doi: 10.1381/096089293765559773. PMID: 10757905.
Copy Download .nbib Format: NLM
Letter to the Editor: Re: "Sarcoidosis Affecting the Periodontium: A Long-Term Follow-Up".

Journal of periodontology

Guzzi G, Brambilla L, Pigatto PD.
PMID: 29539229
J Periodontol. 2008 Jun;79(6):978. doi: 10.1902/jop.2008.070674.

No abstract available.

Cite
Guzzi G, Brambilla L, Pigatto PD. Letter to the Editor: Re: "Sarcoidosis Affecting the Periodontium: A Long-Term Follow-Up". J Periodontol. 2008;79(6):978doi: 10.1902/jop.2008.070674.
Guzzi, G., Brambilla, L., & Pigatto, P. D. (2008). Letter to the Editor: Re: "Sarcoidosis Affecting the Periodontium: A Long-Term Follow-Up". Journal of periodontology, 79(6), 978. https://doi.org/10.1902/jop.2008.070674
Guzzi, Gianpaolo, et al. "Letter to the Editor: Re: "Sarcoidosis Affecting the Periodontium: A Long-Term Follow-Up"." Journal of periodontology vol. 79,6 (2008): 978. doi: https://doi.org/10.1902/jop.2008.070674
Guzzi G, Brambilla L, Pigatto PD. Letter to the Editor: Re: "Sarcoidosis Affecting the Periodontium: A Long-Term Follow-Up". J Periodontol. 2008 Jun;79(6):978. doi: 10.1902/jop.2008.070674. PMID: 29539229.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 50 entries